Aurelia Capital. Board update covering eurozone macro context, portfolio trading, key watch items, and positioning for the next two quarters.
As of 2026-07-15. Source: provided facts; management reporting.
Protect consumer EBITDA through pricing, mix and cost actions with weekly visibility on cash and working capital.
Maintain deployment discipline: prioritize add-ons in industrials and software where demand is more resilient.
Keep exit readiness on schedule: two exits remain planned within 12 months, with gating milestones each quarter.
Modest growth backdrop, consistent with cautious demand assumptions.
Close to target, but still a constraint for consumer spending.
Funding environment remains manageable for refinancings and add-ons.
Stronger euro supports import costs, can pressure exporters.
Source: provided facts (GDP, inflation, ECB rate, EUR/USD).
EUR strength can pressure export pricing. Focus on backlog discipline and cost pass-through.
Supportive rates reduce financing friction for buyers. Prioritize retention and expansion motions.
Inflation at 2.3% keeps value sensitivity elevated. Tighten promo ROI and simplify assortments.
Most defensive exposure. Emphasize compliance, reimbursement stability and pipeline execution.
Given the portfolio mix, our near-term variance to plan is dominated by consumer execution, not macro deterioration.
Source: portfolio sector exposure provided.
| Company | Sector | Status | Primary driver | Near-term focus |
|---|---|---|---|---|
| Company A | Industrials | Above | Backlog conversion | Capacity planning |
| Company B | Software | On plan | Renewals stable | Upsell pipeline |
| Company C | Healthcare | On plan | Volumes steady | Compliance readiness |
| Company D | Industrials | On plan | Input costs easing | Margin discipline |
| Company E | Software | Above | New logo wins | Onboarding scale |
| Company F | Industrials | On plan | Order intake normal | Pricing governance |
| Company G | Consumer | Below | Promo efficiency | Pricing and mix reset |
| Company H | Consumer | Below | Volume softness | SKU rationalization |
| Company I | Healthcare | On plan | Payor stability | Working capital |
| Company J | Software | On plan | Churn contained | Retention playbook |
| Company K | Industrials | Above | Operational leverage | Capex sequencing |
Source: management reporting; status classification provided (2 below plan in consumer).
Primary issue: promo efficiency and margin dilution.
Promo ROI, gross margin per order, inventory days.
Primary issue: volume softness and complexity in assortment.
Sell-through, availability, markdown rate, logistics cost per unit.
Source: portfolio status provided; action plans reflect standard operating levers for consumer variance.
Confirm exit gating milestones each quarter and approve add-on screening concentrated in industrials and software.
Equity story, KPI pack, and quality of earnings scope aligned.
Advisor selection, vendor diligence, buyer mapping.
Launch and execute two exit processes with timing flexibility.
Target completion for both exits, subject to market conditions.
Source: dry powder and exit count provided; timeline expresses sequencing, not a commitment to fixed dates.
Prioritize EBITDA and cash conversion over growth until leading indicators normalize.
Use dry powder for add-ons in industrials and software where integration value is clear.
Run readiness now so we can choose timing, rather than be forced by timelines.
Endorse the consumer stabilization cadence, confirm add-on screening focus, and validate the exit gating plan for the next 12 months.
Source: watch items derived from provided macro indicators and portfolio mix; recommendations align to current exposure and variance drivers.